Evidence map›Paper›PMID 18670609›Full record

ReviewJournal of biomedicine & biotechnology2008

Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis.

Henryka Dlugonska

Abstract readReview
In one paragraph

Review in Journal of biomedicine & biotechnology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. ROP64-DeficientMicroorganisms · 2026
    Article
  2. Article
  3. Completing the pieces of a puzzle: in-depth probing ofClinical and experimental vaccine research · 2024
    Article
  4. Construction and biological function ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. A novel enemy of cancer: recent investigations into protozoan anti-tumor properties.Frontiers in cellular and infection microbiology · 2023
    Review
  10. Anti-Tumor Effect of Parasitic Protozoans.Bioengineering (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Nano DNA Vaccine EncodingPharmaceutics · 2021
    Article
  13. Comparisons of the Sexual Cycles for the Coccidian ParasitesFrontiers in cellular and infection microbiology · 2020
    Review
  14. Article
  15. Article
  16. Rhoptry antigens asClinical and experimental vaccine research · 2019
    Review
  17. Article
  18. Calcium-dependent protein kinases are potential targets forClinical and experimental vaccine research · 2018
    Review
  19. Article
  20. Influenza M1 Virus-Like Particles Consisting ofThe Korean journal of parasitology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Henryka DlugonskaDepartment of Immunoparasitology, Institute of Microbiology and Immunology, University of Lodz, 90-237 Lodz, Poland. hdlugo@biol.uni.lodz.pl

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasma gondii is an obligate intracellular protozoan parasite classified in the phylum Apicomplexa, which includes numerous notable human and animal pathogens (Plasmodium species, Cryptosporidium species, Neospora caninum, etc.). The invasive stages of apicomplexans are characterized by the presence of an apical complex composed of specialized cytoskeletal and secretory organelles, including rhoptries. Rhoptries, unique apical secretory organelles shared exclusively by all apicomplexan parasites, are known to be involved in an active parasite's penetration into the host cell associated with the biogenesis of specific intracellular compartment, parasitophorous vacuole in which the parasite multiplies intensively, avoiding intracellular killing. Due to the key biological role of rhoptries, rhoptry proteins have recently become vaccine candidates for the prevention of several parasitoses, toxoplasmosis among them. The article presents current data on T. gondii rhoptries biology and new approaches to the development of effective vaccines against toxoplasmosis using rhoptry antigens.

Indexed as

AnimalsAntigens, ProtozoanImmunotherapyProtozoan ProteinsProtozoan VaccinesSecretory VesiclesToxoplasmaToxoplasmosisVaccinesAntigens, ProtozoanProtozoan ProteinsProtozoan VaccinesVaccines

Identifiers

PMID18670609
PMCPMC2486357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.